This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

BRUCE J. GANTZ, MD
Iowa City

Arch Otolaryngol Head Neck Surg. 1987;113(10):1042.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A novel approach for the management of bilateral acoustic neuromas in patients with Recklinghausen's disease was reported by Drs Robert Jahrsdoerfer and Robert Benjamin from the Department of Otolaryngology–Head and Neck Surgery, University of Texas Medical School, Houston, and the Department of Medical Oncology, M. D. Anderson Hospital and Tumor Institute, Houston, at the Denver meeting of the American Neurotological Society. Previous attempts at preserving hearing in this patient population have been uniformly poor. The reasons for this have been attributed to the aggressive nature of the tumors to invade the cochlear nerve and otic capsule.

Two adults with bilateral acoustic neuromas caused by Recklinghausen's disease were treated with a combination chemotherapy regimen consisting of doxorubicin hydrochloride, cyclophosphamide, and dacarbazine. One patient received one treatment per month for six months while the other patient received five treatments over five months. Posttreatment imaging studies indicate no increase in tumor size at . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?